Skip to Content
Søk Menu

ASH | American Society of Hematology Meeting & Exposition

ASH 2025

Astrid Hundeboell Torpe

ASH 2025: Prophylactic Tocilizumab Reduces CRS

/ Astrid Hundebøll Torpe
ASH25Multiple myeloma Play the Video

Top Abstract Spotlight: Menin Inhibitors are a Game Changer for the Treatment of Patients with Newly Diagnosed AML 

/ Jan Andreasen
AMLASH25

Fixed-Duration Venetoclax Regimens Match Continuous BTKi in Frontline CLL

/ Jan Andreasen
ASH25CLL

ASH 2025 Highlights – Nordic Webinar 11 December

Stay up to date with the most relevant findings and developments presented at ASH 2025. Nordic experts will highlight key clinical data, emerging treatment strategies, and their potential impact on patient care. Join the live session or watch it on demand at your convenience.

ASH 2024

Betty Gardie & François Girdon

LBA-2: A New Cause of Hereditary and Acquired Erythrocytosis

/ Betty Gardie / Francois Girodon
ASH24 Play the Video

Fabian Müller

Treatment of Autoimmune Patients with CD19-CAR T Cells Results in Long-Term Drug-Free Remission or No Progression

/ Fabian Mueller
ASH24CAR-T Play the Video
Alexander Fuglkjær

Machine Learning Can Reduce Unnecessary Hospitalizations for Cancer Patients

/ Alexander Fuglkjær
AIASH24Lymfom Play the Video
Muhammad Kashif

Novel Risk Stratification Method for Bone Disease in Multiple Myeloma Patients Minimizes Radiation Exposure and Lowers Economic Burden

/ Muhammad Kashif
AIASH24Myelom Play the Video
Ingrid Glimelius

High Infection Burden and Mortality in CLL Patients: A Call for Action

/ Ingrid Glimelius
ASH24CLL Play the Video
Ingrid Glimelius

Zilovertamab Vedotin in Mantle Cell Lymphoma: Promising Results from ASH 2024

/ Ingrid Glimelius
ASH24Lymfom Play the Video
Ingrid Glimelius

High Mortality Rate for Patients with Mantle Cell Lymphoma with a Second Primary Malignancy

/ Ingrid Glimelius
ASH24Lymfom Play the Video

AI Will Play a Significant Role in All Aspects of Hematology in the Future

/ Andrew Srisuwananukorn
AIASH24 Play the Video
Mats Jerkeman

Based on Zuma-7 Studies CAR T-Cell Therapy Is Now Standard Treatment for B-Cell Lymphoma in Scandinavia

/ Mats Jerkeman
ASH24B-celle lymfom Play the Video
Meletios-Athanasios Dimopoulos

Daratumumab Monotherapy Shows Clinical Benefit for Early Intervention for Patients with High-Risk Smoldering Multiple Myeloma

/ Meletios A. Dimopoulos
ASH24Myelom Play the Video
Load more

MEDtalks från ASH 2023

ASH 2023: The Impact of Fitness and Dose Intensity on Safety and Efficacy Outcomes after Venetoclax-Obinutuzumab in Previously Untreated CLL

/ Hematologi / BestPractice Nordic

ASH 2023: FDA Approves Gene Therapies for Sickle Cell Disease

/ Hematologi / BestPractice Nordic

ASH 2023: ELEVATE-TN Study – 6-Year Follow-up of Acalabrutinib Efficacy in CLL

/ Hematologi / BestPractice Nordic

ASH 2023: CAPTIVATE Study – Ibrutinib-Venetoclax for CLL/SLL

/ Hematologi / BestPractice Nordic

ASH 2023: Oral Decitabine-Cedazuridine Tablet Shows Promise for AML Treatment in Phase III Study

/ Hematologi / BestPractice Nordic

Don’t Miss Out on ASH 2023 

/ Hematologi / BestPractice Nordic

Potential for Targeted and Immune-Facing Therapies for Patients with CNS Lymphoma

/ Hematologi / Jason Westin

MRD Status in NPM1 Mutated AML Should Be a Part of the Selection of Patients for Transplant in First Remission

/ Hematologi / Jad Othman

Chemotherapy Might Not Be Needed in Frontline Treatment of Patients with Large B-Cell Lymphoma

/ Hematologi / Jason Westin

Undiagnosed and Unrecognized Patients with a High Bleeding Score

/ Hematologi / Eva Birgitte Leinøe

A Potential New Standard of Care for Transplant-Eligible Patients with Multiple Myeloma

/ Hematologi / Pieter Sonneveld

Hematology 2023

  • Meet the experts
  • 2023
Få tillgang

Mer från ASH 2023

Jeff P. Sharman

No increase risk of Ventricular Arrhythmias and Sudden Death with Acalabrutinib

/ Jeff P. Sharman
ASH23CLL Play the Video
Gabriel Brisou

Real World Data of Axicabtagene Ciloleucel As Second Line Therapy for Patients with Large B-Cell Lymphoma

/ Gabriel Brisou
ASH23B-celle lymfom Play the Video
Hamish Scott & Chris Hahn

ERG deficiency syndrome – maybe a new disease

/ Hamish S. Scott / Christopher Hahn
ASH23 Play the Video
Jeff P. Sharman

Acalabrutinib in Frontline CLL Treatment: Six-Year Results from the Elevate-TN Study

/ Jeff P. Sharman
ASH23CLL Play the Video
Amer Zeidan

New Data on Oral Decitabine in MDS: Real-Life Analysis and Outcomes from ASH2023

/ Amer Zeidan
ASH23 Play the Video
Mats Jerkeman

Key Updates in Mantle Cell Lymphoma from ASH 2023

/ Mats Jerkeman
ASH23Lymfom Play the Video
Mats Jerkeman

CAR-T Cell Therapy as Second-Line Treatment for Elderly Patients with Relapsed/Refractory Large B-Cell Lymphoma

/ Mats Jerkeman
ASH23B-celle lymfom Play the Video
Peter Hillmen

New Standard of Care for Previously Untreated CLL

/ Peter Hillmen
ASH23CLL Play the Video

ASH2023 AI in Hematology: Enhancing Diagnostic Precision for Two Rare Blood Cancers

/ Andrew Srisuwananukorn
AIASH23 Play the Video
Load more

EHA | Kongress

Vi publicerar de viktigaste höjdpunkterna från EHA i form av sammanfattningar, onlineartiklar, MEDtalks med internationella och nationella specialister.

Se allt innehåll

Onkologi / Hematologi • Nr. 1 • 2023

  • Breast Cancer Focus
  • ESMO & Norsk Aften 2023
  • The Link Between Breast Cancer and Hematologic Cancers
Få tillgang

ASh 2022

Updated results on AVO therapeutic triplet regimen in untreated patients with CLL

/ Christine Ryan
ASH22KLL Play the Video

Treatment Options for FLT3 mutant acute myeloid leukemia

/ Eunice Wang
AMLASH22 Play the Video

Significant longer PFS among patients who received zanubrutinib vs ibrutinib

/ Jennifer R. Brown
ASH22KLL Play the Video

Venetoclax plus obinutuzumab er den mest omkostningseffektive behandling af CLL uden del17p/TP53-mutationer

/ Matilde Slot
ASH22KLL Play the Video

Several interesting combinations of therapies with Calquence for patients with CLL

/ Matthew S. Davids
ASH22KLL Play the Video

New combination shows promising efficacy in patients with triple-class refractory R/R multiple myeloma

/ Paul G. Richardson
ASH22Myelom Play the Video
Mer
Back to top